Market Overview

Amgen Higher After Favorable Court Ruling


Amgen, Inc. (NASDAQ: AMGN) shares are trading higher by $5.00 (3.4 percent) at $157.98 in Friday's session.

The catalyst for the rally is a court injunction for infringement of Amgen's Repatha patents against Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi (NYSE: SNY) Praluent drug.

After a higher open, it continued in that direction until finding resistance at $161.00 and reversing course. The ensuing decline has found support well ahead of the top of Thursday's range ($153.40) at $156.67 and has rebounded back to the $158 area.

The issue hasn't closed over $160.00 since October 27, 2016, when it ended the session at $160.57. The following day it fell to $145.18, when the company posted a Q3 beat but lowered FY 2016 guidance.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (AMGN + REGN)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo

Don't Blame Millennials For Being Terrible Employees

Apple Vs. Amazon Vs. Google: Digital Assistants Square Off At CES